Short Communication
Genes and Immunity (2008) 9, 168–175; doi:10.1038/sj.gene.6364449; published online 20 December 2007
IRF-3-dependent and augmented target genes during viral infection
J Andersen1, S VanScoy2, T-F Cheng2, D Gomez2 and N C Reich2
- 1Department of Biochemistry and Cell Biology, Stony Brook University, New York, NY, USA
- 2Department of Molecular Genetics & Microbiology, Stony Brook University, New York, NY, USA
Correspondence: Dr NC Reich, Department of Molecular Genetics & Microbiology, Stony Brook University, Nicolls Rd, Life Sciences Bldg, Stony Brook, New York 11794, USA. E-mail: nreich@notes.cc.sunysb.edu
Received 7 September 2007; Revised 8 November 2007; Accepted 13 November 2007; Published online 20 December 2007.
Abstract
Activation of the transcription factor interferon regulatory factor-3 (IRF-3) is an essential event in the innate immune response to viral infection. To understand the contribution of IRF-3 to host defense, we used a systems biology approach to analyze global gene expression dependent on IRF-3. Comparison of expression profiles in cells from IRF-3 knockout animals or wild-type siblings following viral infection revealed three sets of induced genes, those that are strictly dependent on IRF-3, augmented with IRF-3, or not responsive to IRF-3. Products of identified IRF-3 target genes are involved in innate or acquired immunity, or in the regulation of cell cycle, apoptosis and proliferation. These results reveal the global effects of one transcription factor in the immune response and provide information to evaluate the integrated response to viral infection.
Keywords:
transcription factor, host defense, innate immunity, global profiling, gene expression, signal transduction
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Another detour on the Toll road to the interferon antiviral response
Nature Structural & Molecular Biology News and Views (01 Nov 2004)
A systems view of host defense
Nature Biotechnology News and Views (01 Nov 2009)
RESEARCH
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune Response
Molecular Therapy Original Article
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression
The EMBO Journal Article (11 Jan 2006)
